Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Sells Semiconductor Business to Tara for $26.5M

NEW YORK, Feb. 28 (GenomeWeb News) - PerkinElmer has completed the sale of its semiconductor business to Tara Capital, the photonics company said today.

 

The assets were sold for approximately $26.5 million in cash and assumed liabilities and an earn-out that could increase that amont to more than $30 million, PerkinElmer said in a statement.

 

The sale, which PerkinElmer originally expected to close by the end of last year, follows the December 2005 sale of PerkinElmer's aerospace division to Eaton and represents the last of the companies' divestitures of its fluid sciences units.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.